Summary Stage 2018: Melanoma Head and Neck

Summary Stage 2018


**Melanoma Head and Neck** 8720-8790 (C003-C005, C008-C069, C090-C148, C300-C329) **Note 1:** The following sources were used in the development of this chapter * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) ( * SEER Summary Staging Manual-2000: Codes and Coding Instructions ( * Collaborative Stage Data Collection System, version 02.05: * Chapter 14 *Mucosal Melanoma of the Head and Neck*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** Mucosal melanomas occur throughout the mucosa of the lip and oral cavity (C003-C005, C008-C069, C090-C148) and the nasal cavity and middle ear (C300-C301), accessory sinuses (C310-C319) and the larynx (C320-C329). For a more detailed description of anatomy, refer to the appropriate Summary Stage 2018 chapter based on the location of the mucosal melanoma. **Note 3:** Code 1 for localized tumors when no other information is available or for extension involving the mucosa only of adjacent sites. **Note 4:** Extension involving the deeper tissues of the primary or adjacent sites are either regional or distant, depending on the involvement. * Code 2 for regional when the only information available is "deep tissue involvement." **Note 5:** The description of lymph nodes has been standardized across the head and neck chapters. Levels I-VII and the "other" lymph nodes are regional (code 3).


SS2018 Description
0 In situ: noninvasive, intraepithelial
1 Localized only (localized, NOS) - Confined to site of origin, NOS - Mucosa WITH or WITHOUT soft tissue (immediately underlying)
2 Regional by direct extension only - Deep soft tissue involvement - Moderately advanced disease, NOS - Overlying skin
3 Regional lymph node(s) involved only - Level I + Level IA - Submental + Level IB - Submandibular (submaxillary), sublingual - Level II - Upper jugular + Jugulodigastric (subdigastric) + Upper deep cervical + Level IIA - Anterior + Level IIB - Posterior - Level III - Middle jugular + Middle deep cervical - Level IV - Lower jugular + Jugulo-omohyoid (supraomohyoid) + Lower deep cervical + Virchow node - Level V - Posterior triangle group + Posterior cervical + Level VA - Spinal accessory + Level VB - Transverse cervical, supraclavicular - Level VI - Anterior compartment group + Laterotracheal + Paralaryngeal + Paratracheal - above suprasternal notch + Perithyroidal + Precricoid (Delphian) + Prelaryngeal + Pretracheal - above suprasternal notch + Recurrent laryngeal - Level VII - Superior mediastinal group (for other mediastinal node(s) see code 7) + Esophageal groove + Paratracheal - below suprasternal notch + Pretracheal - below suprasternal notch - Other groups + Cervical, NOS + Deep cervical, NOS + Facial * Buccinator (buccal) * Mandibular * Nasolabial + Internal jugular, NOS + Parapharyngeal + Parotid * Infraauricular * Intraparotid * Periparotid * Preauricular + Retroauricular (mastoid) + Retropharyngeal + Suboccipital - Regional lymph node(s), NOS + Lymph node(s), NOS
4 Regional by BOTH direct extension AND regional lymph node(s) involved - Codes (2) + (3)
7 Distant site(s)/lymph node(s) involved - Distant site(s) (including further contiguous extension) + Bone + Brain + Cartilage + Carotid artery + Deep extrinsic muscle of tongue * Genioglossus * Hyoglossus * Palatoglossus * Styloglossus + Dura + Lower cranial nerves (IX, X, XI, XII) + Masticator space + Mediastinal structures + Prevertebral space + Skull base + Very advanced disease, NOS - Distant lymph node(s), NOS + Mediastinal (excluding superior mediastinal node(s)) - Distant metastasis, NOS + Carcinomatosis + Distant metastasis WITH or WITHOUT distant lymph node(s)
9 Unknown if extension or metastasis
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL) (4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30 (5) Lydiatt, W.M., Patel, S.G., Shah, J.P., et al. **Staging Head and Neck Cancers**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 55-65 (6) Lydiatt, W.M., Brandwein-Gensler, M., Shah, J.P., et al. **Mucosal Melanoma of the Head and Neck**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 163-169